London, UK (PRWEB) May 31, 2013
The USA is the leading point-of-care testing (POCT) market on a global scale. In 2009, the US POCT market generated revenues of USD 2.1 billion. The market is predicted to climb to above USD 3.9 billion in 2016 considerably driven by high-growth sectors such as coagulation PT monitoring and infectious disease.
Abbott, Diagnocure, Agilent Technologies, Ortho-Clinical Diagnostics, Mackay Life Sciences and ThermoFisher are only few prominent participants of the US POCT space.
New research report “Emerging US Point-of-Care Testing Market: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers” prepared by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.
Title: Emerging US Point-of-Care Testing Market: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers
Published: May, 2013
Price: US$ 12,500.00
The report provides an in-depth analysis of the US POCT market. It contains comprehensive examination of the key market segments, including data on their dynamics and size; characterizes regulatory policies related to the industry; traces prevailing technological trends. The study evaluates competitive pressure and profiles leading market players; outlines emerging industry opportunities. The research reviews currently available products and those under development; includes sales and market share analysis; identifies potential market entry barriers and risks. In addition, the report present detailed future forecast of the industry development.
More new research reports by the publisher can be found at VPG page.
Read the full story at http://www.prweb.com/releases/2013/5/prweb10789213.htm.
Copyright©2012 Vocus, Inc.
All rights reserved